AMRUTANJAN HEALTH CARE
|
AMRUTANJAN HEALTH CARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 17.58 | 15.56 | 13.63 | 22.99 | 20.93 |
| CEPS(Rs) | 19.84 | 17.65 | 15.41 | 24.28 | 22.19 |
| DPS(Rs) | 4.60 | 4.60 | 4.60 | 4.60 | 4.20 |
| Book NAV/Share(Rs) | 112.83 | 99.92 | 99.12 | 90.49 | 73.53 |
| Tax Rate(%) | 26.47 | 27.40 | 25.74 | 25.82 | 25.29 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 12.91 | 12.32 | 11.73 | 19.11 | 20.20 |
| EBIT Margin(%) | 15.37 | 14.77 | 14.19 | 22.46 | 24.79 |
| Pre Tax Margin(%) | 15.30 | 14.71 | 14.13 | 22.32 | 24.61 |
| PAT Margin (%) | 11.25 | 10.68 | 10.49 | 16.56 | 18.38 |
| Cash Profit Margin (%) | 12.70 | 12.11 | 11.87 | 17.49 | 19.49 |
| Performance Ratios | |||||
| ROA(%) | 13.00 | 12.47 | 11.32 | 21.78 | 25.94 |
| ROE(%) | 16.53 | 15.54 | 14.37 | 28.03 | 32.69 |
| ROCE(%) | 22.58 | 21.47 | 19.38 | 37.93 | 44.00 |
| Asset Turnover(x) | 1.16 | 1.17 | 1.08 | 1.32 | 1.41 |
| Sales/Fixed Asset(x) | 5.73 | 5.63 | 6.26 | 9.31 | 8.50 |
| Working Capital/Sales(x) | 2.19 | 1.87 | 1.93 | 2.06 | 1.95 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.17 | 0.18 | 0.16 | 0.11 | 0.12 |
| Receivable days | 41.89 | 35.05 | 34.26 | 25.15 | 24.19 |
| Inventory Days | 22.69 | 25.01 | 26.36 | 19.54 | 22.58 |
| Payable days | 102.13 | 89.00 | 108.19 | 102.26 | 93.75 |
| Valuation Parameters | |||||
| PER(x) | 36.67 | 39.77 | 42.19 | 34.53 | 27.15 |
| PCE(x) | 32.50 | 35.05 | 37.31 | 32.69 | 25.61 |
| Price/Book(x) | 5.72 | 6.19 | 5.80 | 8.77 | 7.73 |
| Yield(%) | 0.71 | 0.74 | 0.80 | 0.58 | 0.74 |
| EV/Net Sales(x) | 3.94 | 4.18 | 4.24 | 5.50 | 4.57 |
| EV/Core EBITDA(x) | 23.44 | 25.81 | 27.26 | 23.51 | 17.66 |
| EV/EBIT(x) | 25.64 | 28.33 | 29.89 | 24.49 | 18.45 |
| EV/CE(x) | 5.45 | 6.11 | 5.54 | 6.45 | 5.62 |
| M Cap / Sales | 4.13 | 4.25 | 4.43 | 5.72 | 4.99 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 7.26 | 10.96 | -6.46 | 21.93 | 27.29 |
| Core EBITDA Growth(%) | 11.33 | 15.53 | -37.78 | 10.20 | 120.08 |
| EBIT Growth(%) | 11.68 | 15.46 | -40.91 | 10.50 | 137.11 |
| PAT Growth(%) | 13.03 | 12.90 | -40.71 | 9.80 | 143.95 |
| EPS Growth(%) | 13.04 | 14.15 | -40.71 | 9.80 | 143.95 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 3.44 | 4.23 | 4.13 | 3.55 | 4.28 |
| Quick Ratio(x) | 3.11 | 3.82 | 3.67 | 3.21 | 3.94 |
| Interest Cover(x) | 213.00 | 247.90 | 241.99 | 156.66 | 139.35 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of AMRUTANJAN HEALTH CARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMRUTANJAN HEALTH CARE | ₹2,083.8 Cr | 0.9% | -4.3% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,471.0 Cr | 0.3% | 4.1% | -9.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,294.0 Cr | -1.7% | 8.5% | 13.2% | Stock Analytics | |
| CIPLA | ₹127,946.0 Cr | -3.4% | 3% | 4.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,691.0 Cr | 0.7% | -0.5% | 7.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,214.0 Cr | 0.2% | -1.1% | -3.6% | Stock Analytics | |
AMRUTANJAN HEALTH CARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMRUTANJAN HEALTH CARE | 0.9% |
-4.3% |
-2.3% |
| SENSEX | 1% |
3.3% |
4.5% |
You may also like the below Video Courses
